Stroke-Preventing device studied in atrial fibrillation patients
NCT ID NCT06189365
First seen Dec 18, 2025 · Last updated Jun 05, 2026 · Updated 28 times
Summary
This study tested a device called the Amplatzer Amulet in 50 Chinese adults with non-valvular atrial fibrillation who cannot take long-term blood thinners. The device is implanted to close off a part of the heart where clots can form, aiming to prevent strokes. The study looked at safety and effectiveness over two years, but it was terminated early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-VALVULAR ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, 410013, China
-
University of Hong Kong-Shenzhen Hospital
Shenzhen, Guangdong, 518009, China
-
Wuhan Asia Heart Hospital
Wuhan, Hubei, 430022, China
-
Xiangya Hospital Zhuzhou Central South University
Zhuzhou, Hunan, 412007, China
-
Xianyang Hospital Of Yan'an University
Xianyang, Shaanxi, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.